Business Wire

Bulgaria Joins European Biobanking Research Infrastructure as Full Member

Jaa

Bulgaria has joined the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC) at its Assembly of Members, which took place in Bologna on the 23rd May 2018.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180604005699/en/

Bulgaria Joins European Biobanking Research Infrastructure as Full Member (Photo: Business Wire)

Bulgaria Joins European Biobanking Research Infrastructure as Full Member (Photo: Business Wire)

Bulgaria will be represented by the Medical University – Sofia and becomes the 21st Member. MUS is the coordinating institution of the National University Complex for Biomedical and Applied Research infrastructure, which has been part of the National Roadmap for RIs since 2014. The Ministry of Education and Science is the financial coordinator of all RIs included in the Roadmap. In the coming months, both the Bulgarian Ministry of Education and Science and MUS will work with BBMRI-ERIC to set up the BBMRI National Node.

Bulgarian Minister of Education and Science Mr Krasimir Valchev said, “I would like first to thank BBMRI-ERIC for the warm welcome of the Bulgarian biobanking and biomedical community to their European family. I am proud that we have excellent research teams who collaborate world-wide and I am convinced we should further strengthen our policies and instruments in support of our bright minds and the research and innovation development in the country. Among our European priorities are acceleration of knowledge transfer and increased access to research results, including via fostering European open science initiatives and ensuring long-term sustainability and openness of pan-European research infrastructures. Bulgaria is committed to continuing its efforts to contribute to the European research area main pillars and common goals.”

BBMRI-ERIC’s Director General Erik Steinfelder said, “It is with great pleasure I welcome Bulgaria to BBMRI-ERIC. Bulgarian biobanks are now connected to the world like never before. At the same time, Bulgarian researchers and biobankers will have access to knowledge, IT tools, and tailor-made guidance by BBMRI-ERIC that will support the further development”.

“This is also a milestone for European research in general”, Steinfelder commented. “While other countries are decreasing investment in research, Bulgaria is showing the way, boosting the development of its biomedical sector”.

Steinfelder concluded saying: “BBMRI-ERIC believes in providing services to Make New Treatments Possible, however, biomedical research does not take place in a vacuum: it requires a multidisciplinary approach. That’s why we are increasing our collaboration with other ERICs to ensure that, in the future, research infrastructures in biomedical research. That is also why we welcome the Council conclusions on accelerating knowledge circulation within the EU: we are going in the same direction”.

BBMRI-ERIC brings together more than 500 biobanks from its Members and one international organisation. The BBMRI-ERIC Directory, the largest sample catalogue in the world, allows users to search more than 100 million samples online. BBMRI’s mission is to facilitate access to biological resources and biomedical facilities and is a central player to when it comes to “Make New Treatments Possible”.

BBMRI is an international organisation established under EU legislation. Its headquarters are in Graz, Austria, and it has a liaison office in Brussels.

BBMRI-ERIC provides support and services to local biobanks via its National Nodes (one per country). The National Nodes are fully involved in the day-to-day management of BBMRI-ERIC and provide feedback from the national level. BBMRI-ERIC services cover three main areas: ethical, legal and societal issues (ELSI), quality management, and IT solutions that allow users to search collections online and request access:

Editor’s Note:

BBMRI-ERIC Members: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Italy, Malta, Latvia, the Netherlands, Norway, Poland, Sweden, United Kingdom

BBMRI-ERIC Observers: Cyprus, Switzerland, Turkey, IARC/WHO

Contact information

BBMRI-ERIC
Luc Deltombe
Communications Manager
Email: luc.deltombe@bbmri-eric.eu
Phone: +43 316 349 917 21
www.bbmri-eric.eu

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)22.9.2018 01:13Tiedote

Glorious beaches by day and theme park fireworks by night just got more convenient for Philadelphia travelers. American Airlines announced today that it will begin nonstop flights to Orlando Melbourne International Airport (MLB) starting February 16, 2019. The Central Florida airport is conveniently located in the heart of the tourism region and is the closest airport to NASA rocket launches, Port Canaveral’s cruises and what critics call “some of the most beautiful beaches Florida has to offer.” The flights will depart Saturdays from Philadelphia at 8:05 a.m., arriving in Florida at 10:48 a.m. The Embraer 175 jet arrival time syncs perfectly with cruise ship noon early boarding. Melbourne Airport Express offers nonstop shuttle service to the port, and all major rental car companies are onsite. The return flight to PHL departs at 11:24 a.m. and arrives in PHL at 1:55 p.m., with enough time to connect to some of American’s largest international destinations, including recently announced

Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice21.9.2018 20:43Tiedote

BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced that Amy Palladino has joined the agency as Executive Vice President, Managing Director in the agency’s U.S. Corporate Practice. Based in New York, Palladino will focus on senior client counsel and executive positioning for the agency’s largest corporate clients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005507/en/ Amy Palladino Joins BCW (Burson Cohn & Wolfe) “Amy is a talented and highly experienced communications executive with a track record of solving clients’ complex challenges and building business through smart, integrated communications approaches,” said Chris Foster, President, North America, BCW. “Her creativity and judgement will be enormously valuable to our current and prospective clients.” Palladino has more than 20 years of experience advising global clients across numerous industries, including technology, healthcar

Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 19:41Tiedote

Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo

Florian Winterstein Becomes New CEO of Jedox21.9.2018 18:46Tiedote

The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it

Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter21.9.2018 17:37Tiedote

Since 2010 Avinor has had a vision and a desire to automate winter maintenance. In March autonomous snow clearing was demonstrated at Fagernes Airport, and this winter Avinor is taking this a step further by testing two autonomous snowploughs at Oslo Airport. The project is one of the first globally where large machinery will operate autonomously to keep snow away from airport areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005363/en/ Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter (Photo: Business Wire) “Innovation is important to Avinor. In the future, many tasks in aviation will be resolved in other ways than today. Avinor wants to test autonomy, and does of course see a potential for rationalization in the future through new solutions for winter operations and in other areas. Avinor is at the forefront of testing this technology, but it is essential that safety is ensured in all such testing

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 16:30Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme